In osteosarcoma, LB-100 and cisplatin treatments resulted in decreased ATM/ATR-mediated DNA damage response, leading to hyperphosphorylation of checkpoint kinase 1 (Chk1) and Chk2, and subsequently causing an increase of cyclin activity in these cells [129]. This evidence concerns the gene CHEK1 and osteosarcoma.